These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2753981)

  • 1. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
    McElduff A; Posen S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
    Lyles KW; Drezner MK
    J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
    J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.
    Nesbitt T; Drezner MK; Lobaugh B
    J Clin Invest; 1986 Jan; 77(1):181-7. PubMed ID: 3753708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
    Aarskog D; Aksnes L; Markestad T
    Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
    Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y
    Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
    Short E; Morris RC; Sebastian A; Spencer M
    J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
    Pettifor JM
    Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal regulation of calcitriol production in Gy mice. Evidence for biochemical heterogeneity in the X-linked hypophosphatemic diseases.
    Davidai GA; Nesbitt T; Drezner MK
    J Clin Invest; 1990 Feb; 85(2):334-9. PubMed ID: 2153705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
    N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the mechanism for abnormal renal 25-hydroxyvitamin D3-1-hydroxylase activity in the X-linked Hyp mouse.
    Tenenhouse HS
    Endocrinology; 1984 Aug; 115(2):634-9. PubMed ID: 6086274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE; Glorieux FH
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice.
    Meyer RA; Gray RW; Roos BA; Kiebzak GM
    Endocrinology; 1982 Jul; 111(1):174-7. PubMed ID: 6896304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Jones G
    J Clin Invest; 1990 May; 85(5):1450-5. PubMed ID: 2332500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal 24-hydroxylation of 25-hydroxyvitamin D in the X-linked hypophosphatemic mouse.
    Cunningham J; Gomes H; Seino Y; Chase LR
    Endocrinology; 1983 Feb; 112(2):633-8. PubMed ID: 6600222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF
    Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.
    Chesney RW; Hamstra AJ; Phelps M; DeLuca HF
    Kidney Int Suppl; 1983 Nov; 15():S63-9. PubMed ID: 6584678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of X-linked hypophosphatemic rickets.
    Chung WT; Niu DM; Lin CY
    Acta Paediatr Taiwan; 2002; 43(1):26-34. PubMed ID: 11890223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal calcitonin stimulation of serum calcitriol in patients with X-linked hypophosphatemic rickets.
    Econs MJ; Lobaugh B; Drezner MK
    J Clin Endocrinol Metab; 1992 Aug; 75(2):408-11. PubMed ID: 1639943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.